Driving research of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS), Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia and Post COVID .
Demonstrates a significant difference between ME/CFS patients and healthy controls.
LEAD INVESTIGATORS
Julie Wilhelmy, SGTC
Ronald W. Davis, PhD
UPDATES AND POTENTIAL
Coming soon...
TECHNOLOGY DESCRIPTION
Julie Wilhelmy, SGTC
Developed by Julie Wilhelmy, PhD, in collaboration with Ronald W. Davis, PhD, at Stanford University.
The Seahorse instrument measures oxygen during energy production processes that occur in the mitochondria. A protocol using the Seahorse has revealed a significant difference between activated T-cells of ME/CFS patients and healthy controls.
The instrument is commercially available, which will allow other laboratories to easily reproduce the results.